Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ursula Petzold"'
Autor:
Ullrich Munzel, Jean Bousquet, Joachim Maus, Robert Hermann, Hermann Mascher, Hartmut Derendorf, Ursula Petzold
Publikováno v:
British Journal of Clinical Pharmacology. 74:125-133
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The topical second generation anti-histamine azelastine hydrochloride (AZE) and the potent corticosteroid fluticasone propionate (FP) are well established first-line treatments in allergic rhinitis (AR).
Autor:
Ursula Petra Zieglmayer, Alexander Kavina, Ullrich Munzel, Kristina Marschall, Friedrich Horak, Ursula Petzold, René Zieglmayer
Publikováno v:
Current Medical Research and Opinion. 22:151-157
To assess the efficacy and onset of action of azelastine nasal spray and desloratadine tablets in patients with allergen-induced seasonal allergic rhinitis (SAR).46 adult patients with a history of SAR were exposed to a controlled grass pollen concen
Autor:
R. Hermann, C. Kolb, Ursula Petzold, Giorgio Walter Canonica, Giorgio Ciprandi, B. Ellers-Lenz
Publikováno v:
Current Medical Research and Opinion. 19:321-329
Azelastine is a selective H(1)-receptor antagonist that inhibits histamine release and interferes with activation of several other mediators of allergic inflammation. Together with demonstrated efficacy in seasonal allergic conjunctivitis, azelastine
Autor:
Hans-Joachim Kremer, Joachim Maus, Bernhard Pfannebecker, Ullrich Munzel, Duc Tung Nguyen, Josef Lecheler, Ursula Petzold
Publikováno v:
Scopus-Elsevier
Background: The leukotriene inhibitor montelukast has been recommended against exercise-induced asthma (EIA), however, single-dose agents might be favourable in several aspects. Objective: To compare the protective effects against EIA of a single inh
Autor:
Joachim Maus, Ullrich Munzel, Duc Tung Nguyen, Hans-Joachim Kremer, Ursula Petzold, Hartmut Dietrich
Publikováno v:
Journal of aerosol medicine and pulmonary drug delivery. 21(3)
The present study aimed at assessing the pharmacokinetics (PK) and safety pharmacodynamics (PD) of 24 microg formoterol delivered via a Novolizer and via an Aerolizer in healthy subjects. This was a randomized, open-label, crossover study. Beside PK,
Autor:
Artur Bauhofer, Andreas Pahl, Peter Jürgen Cnota, Joachim Maus, Stefan Szelenyi, Ursula Petzold, Kay Brune
Publikováno v:
Biochemical pharmacology. 72(12)
Currently, much effort is geared towards developing therapies that impact on the inflammation in respiratory diseases such as asthma and COPD, assuming that this will improve disease pathology. R,R-Glycopyrrolate, a quaternary ammonium compound, is a
Autor:
Robert Hermann, Ozod Nazarov, Ursula Petzold, Duc Tung Nguyen, Barbara Ellers-Lenz, Hans Haase
Publikováno v:
Arzneimittel-Forschung. 53(3)
Azelastine (CAS 58581-89-8) is a selective H1-receptor antagonist that inhibits histamine release and interferes with activation of other mediators of allergic inflammation. The present double-blind study aimed to evaluate azelastine eye drops (Aller
Autor:
Ursula Petzold, Hans-Joachim Kremer, Duc Tung Nguyen, Ullrich Munzel, Hartmut Dietrich, Joachim Maus
Publikováno v:
Journal of Aerosol Medicine & Pulmonary Drug Delivery; Vol. 21 Issue 3, p309-320, 12p